Emerging technologies

Innovation in Pharmaceutical Biotechnology: Comparing National Innovation Systems at the Sectoral Level

 

 


ISBN: 92-64-01403-9
Published: 29/03/2006
Pages: 187

 

What are the specific characteristics of innovation in pharmaceutical biotechnology?

 

How do biopharmaceutical innovation systems in OECD countries perform and which policies are suitable to foster performance?

This publication examines the innovation system in pharmaceutical biotechnology in eight OECD countries: Belgium, Finland, France, Germany, Japan, the Netherlands, Norway and Spain. It summarises the results of in-depth studies, providing a comparative analysis of participating countries' performance in science and innovation in biopharmaceuticals. It highlights specific characteristics of the national biopharmaceutical innovation systems in terms of their international openness and the specific role of demand-side factors in the innovation process. Major systemic failures affecting the functioning of the biopharmaceutical innovation systems are identified. Based on rich evidence, the report draws policy recommendations to foster innovation in biopharmaceuticals advocating an integrated policy approach.

This study forms part of a larger effort to compare innovation processes in different industry sectors and technological fields to provide policy guidance and to more fully elaborate the national innovation systems (NIS) approach to policy making.


Table of contents

Foreword

ecutive Summary (English) - available for free download

Note de synthèse (French) - available for free download

Chapter 1. Introduction

Chapter 2. Summary of Country Studies:
  Belgium
  Finland
  France
  Germany
  Japan
  The Netherlands
  Norway
  Spain

Chapter 3. Comparison of Performance in National Biopharmaceutical Innovation Systems

Chapter 4. Openness of the Biopharmaceutical Innovation System

Chapter 5. Comparison of Selected Demand-side Factors

Chapter 6. Structure, Dynamics and Performance in National Biopharmaceutical Innovation Systems

Chapter 7. Systemic Imperfections in Biopharmaceutical Innovation Systems

Chapter 8. Policy Implications

The full volume can be browsed on the OECD Online Bookshop.


How to obtain this publication

Readers can access the full version of the book choosing from the following options: